Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mir A Ali

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cell|October 24, 2006
Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spreadQingxue Li, Mir A Ali, Jeffrey I Cohen
Virology|March 11, 2014
Activation of H2AX and ATM in varicella-zoster virus (VZV)-infected cells is associated with expression of specific VZV genesTakenobu Yamamoto, Mir A Ali, XueQiao Liu, et al.
Journal of Virology|December 8, 2006
Absence or overexpression of the Varicella-Zoster Virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces VZV latency in a rodent modelJeffrey I Cohen, Tammy Krogmann, Lesley Pesnicak, et al.
Virology|February 24, 2009
The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infectionMir A Ali, Qingxue Li, Elizabeth R Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Periodic Illness Associated With Epstein-Barr Virus: A New Diagnosis After a 22-Year Follow-upLesia K Dropulic, Mir A Ali, Amanda K Ombrello, et al.
Journal of Virology|June 8, 2007
The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptorQingxue Li, Tammy Krogmann, Mir A Ali, et al.
Vaccine|June 15, 2004
Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challengeThomas C Heineman, Lesley Pesnicak, Mir A Ali, et al.
The Journal of Infectious Diseases|July 23, 2002
Polymorphisms in the genes for herpesvirus entryAndriani Patera, Mir A Ali, Stephen Tyring, et al.
Diagnostic Microbiology and Infectious Disease|May 13, 2014
Whole genome mapping of the first reported case of KPC-2-positive Klebsiella pneumoniae ST258 in NebraskaRandal C Fowler, Caitlyn R Scharn, Mir A Ali, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assayJeffrey I Cohen, Mir A Ali, Ahmad Bayat, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cell|October 24, 2006
Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spreadQingxue Li, Mir A Ali, Jeffrey I Cohen
Virology|March 11, 2014
Activation of H2AX and ATM in varicella-zoster virus (VZV)-infected cells is associated with expression of specific VZV genesTakenobu Yamamoto, Mir A Ali, XueQiao Liu, et al.
Journal of Virology|December 8, 2006
Absence or overexpression of the Varicella-Zoster Virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces VZV latency in a rodent modelJeffrey I Cohen, Tammy Krogmann, Lesley Pesnicak, et al.
Virology|February 24, 2009
The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infectionMir A Ali, Qingxue Li, Elizabeth R Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Periodic Illness Associated With Epstein-Barr Virus: A New Diagnosis After a 22-Year Follow-upLesia K Dropulic, Mir A Ali, Amanda K Ombrello, et al.
Journal of Virology|June 8, 2007
The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptorQingxue Li, Tammy Krogmann, Mir A Ali, et al.
Vaccine|June 15, 2004
Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challengeThomas C Heineman, Lesley Pesnicak, Mir A Ali, et al.
The Journal of Infectious Diseases|July 23, 2002
Polymorphisms in the genes for herpesvirus entryAndriani Patera, Mir A Ali, Stephen Tyring, et al.
Diagnostic Microbiology and Infectious Disease|May 13, 2014
Whole genome mapping of the first reported case of KPC-2-positive Klebsiella pneumoniae ST258 in NebraskaRandal C Fowler, Caitlyn R Scharn, Mir A Ali, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assayJeffrey I Cohen, Mir A Ali, Ahmad Bayat, et al.
Pageof 3